Patents Examined by Srikanth Patury
-
Patent number: 10499650Abstract: The present invention provides methods for development of a virulent bacteriophage-based treatment for the control of plant diseases caused by Xylella fastidiosa. The invention further provides methods of isolating and propagating bacteriophage virulent to X. fastidiosa in a Xanthomonas bacterial host and for treating or reducing symptoms of X. fastidiosa infection in a plant. The invention further provides methods of isolating and propagating bacteriophage virulent to Xanthomonas axonopodis pv. citri and for treating or reducing symptoms of Xanthomonas axonopodis pv. citri infection in a plant.Type: GrantFiled: October 18, 2013Date of Patent: December 10, 2019Assignee: The Texas A&M University SystemInventors: Carlos F. Gonzalez, Stephen J. Ahern, Mayukh Das, Ryland F. Young, III, Tushar Suvra Bhowmick
-
Patent number: 10499651Abstract: Methods and compositions are provided for preventing or reducing symptoms or disease associated with Xylella fastidiosa or Xanthomonas axonopodis in a plant. The invention provides novel bacteriophages virulent to Xylella fastidiosa or Xanthomonas axonopodis, including XfaMija and XfaMijo, and further provides methods for treating or preventing Pierce's Disease or Citrus Canker in plants.Type: GrantFiled: June 6, 2016Date of Patent: December 10, 2019Assignee: The Texas A&M University SystemInventors: Carlos F. Gonzalez, Stephen J. Ahern, Mayukh Das, Ryland F. Young, III, Tushar Suvra Bhowmick
-
Patent number: 10481071Abstract: Systems and methods for analyzing blood samples, and more specifically for performing a white blood cell (WBC) differential analysis. The systems and methods screen WBCs by means of fluorescence staining and a fluorescence triggering strategy. As such, interference from unlyzed red blood cells (RBCs) and fragments of lysed RBCs is substantially eliminated. The systems and methods also enable development of relatively milder WBC reagent(s), suitable for assays of samples containing fragile WBCs. In one embodiment, the systems and methods include: (a) staining a blood sample with an exclusive cell membrane permeable fluorescent dye, which corresponds in emission spectrum to an excitation source of a hematology instrument; (b) using a fluorescence trigger to screen the blood sample for WBCs; and (c) using measurements of (1) axial light loss, (2) intermediate angle scatter, (3) 90° polarized side scatter, (4) 90° depolarized side scatter, and (5) fluorescence emission to perform a differentiation analysis.Type: GrantFiled: September 14, 2017Date of Patent: November 19, 2019Assignee: Abbott LaboratoriesInventors: Jiong Wu, Giacomo Vacca
-
Patent number: 10481072Abstract: Systems and methods for analyzing blood samples, and more specifically for performing a nucleated red blood cell (nRBC) analysis. The systems and methods screen a blood sample by means of fluorescence staining and a fluorescence triggering strategy, to identify nuclei-containing particles within the blood sample. As such, interference from unlysed red blood cells (RBCs) and fragments of lysed RBCs is substantially eliminated. The systems and methods also enable development of relatively milder reagent(s), suitable for assays of samples containing fragile white blood cells (WBCs). In one embodiment, the systems and methods include: (a) staining a blood sample with an exclusive cell membrane permeable fluorescent dye; (b) using a fluorescence trigger to screen the blood sample for nuclei-containing particles; and (c) using measurements of light scatter and fluorescence emission to distinguish nRBCs from WBCs.Type: GrantFiled: September 14, 2017Date of Patent: November 19, 2019Assignee: Abbott LaboratoriesInventors: Jiong Wu, Marilou Coleman, Emily H. Lin, Michael R. Buhl, Giacomo Vacca
-
Patent number: 10481073Abstract: Provided herein are systems and methods for analyzing blood samples, and more specifically for performing a basophil analysis. In one embodiment, the systems and methods include: (a) staining a blood sample with an exclusive cell membrane permeable fluorescent dye; and then (b) using measurements of light scatter and fluorescence emission to distinguish basophils from other WBC sub-populations. In one embodiment, the systems and methods include performing a basophil cluster analysis of the blood sample, based on the combination of light scatter and fluorescence measurements.Type: GrantFiled: November 1, 2017Date of Patent: November 19, 2019Assignee: Abbott LaboratoriesInventors: Jiong Wu, Michael R. Buhl, Giacomo Vacca
-
Patent number: 10457610Abstract: The present invention comprises methods and compositions comprising a microalgae consortium. A composition comprises at least one genera of microalgae flocculated by Paenibacillus polymyxa strain, Strain 2, deposited under the Budapest Treaty as ATCC Accession No. PTA-12841. Methods of treating the soil comprise adding a composition of the present invention to soil.Type: GrantFiled: August 12, 2016Date of Patent: October 29, 2019Assignee: Core Intellectual Properties Holdings, LLCInventors: Luke Blotsky, Karin L. Hastings, Derex Q. Zellars
-
Patent number: 10435726Abstract: Processes for transesterifying wax esters. Implementations may include providing a feedstock including wax esters, introducing into the feedstock an alcohol with a carbon number ranging from 1 to 34 carbons where the alcohol is selected from the group consisting of a straight chain alcohol, a branched chain alcohol, any combination of straight chain alcohols, any combination of branched chain alcohols, and any combination thereof. The process may include contacting the feedstock with a lipase, and catalytically transesterifying the wax esters in the feedstock with the lipase to form a transesterified product. The enzymatically transesterified product may be adapted to produce a finished product having a certain formula that has a viscosity that substantially matches a viscosity of a finished product having the same certain formula including chemically catalyzed transesterified wax esters.Type: GrantFiled: August 31, 2015Date of Patent: October 8, 2019Assignee: International Flora Technologies, Ltd.Inventors: Jeff Addy, James H. Brown
-
Patent number: 10433538Abstract: Disclosed herein are solutions for use with machine perfusion of one or more organs. In some embodiments, the solutions comprise acellular cross-linked hemoglobin in a physiologically acceptable medium. Also disclosed herein are methods for machine perfusion of one or more organs, for example utilizing the disclosed perfusion solutions. In some embodiments, the methods include perfusing an organ with an oxygenated solution (such as the disclosed solutions) which is at a temperature between about 12-37° C., for example at a temperature of about 21° C.Type: GrantFiled: October 11, 2013Date of Patent: October 8, 2019Assignee: University of Pittsburgh—Of the Commonwealth System of Higher EducationInventors: Paulo Artur Chaves Fontes, William R. Light
-
Patent number: 10405961Abstract: Disclosed herein are medical products, including a surgical mesh, with a layer of dehydrated modified basement membrane preparation formed thereon. The basement membrane has been modified before dehydration of remove low molecular weight components. In some embodiments, the basement membrane is crosslinked. Methods of making and using the products also are disclosed.Type: GrantFiled: September 2, 2016Date of Patent: September 10, 2019Assignee: Cell and Molecular Tissue Engineering, LLCInventors: Ulrike W. Klueh, Donald L. Kreutzer
-
Patent number: 10407709Abstract: A method of isolating cells includes providing a microfluidic device having at least one microfluidic channel coupled to an inlet and an outlet, the at least one microfluidic channel comprises at least one expansion region disposed along the length thereof. The at least one expansion region is an abrupt increase in a cross-sectional dimension of the at least one microfluidic channel configured to generate a vortex within the at least one expansion region in response to fluid flow. A solution containing a population of cells at least some of which have diameters ?10 ?m flows into the inlet. A portion of cells is trapped within vortex created within the at least one expansion region. The trapped cells may then released from the expansion region.Type: GrantFiled: August 5, 2015Date of Patent: September 10, 2019Assignee: THE REGENTS OF THE UNIVERSITY OF CALIFORNIAInventors: Dino Di Carlo, Soojung C. Hur, Albert J. Mach
-
Patent number: 10391200Abstract: Cosmetic methods providing a significant improvement over existing hair transplantation methods by providing greater hair density per hair implant, which is achieved through the process of an enhanced hair multiplication in vivo (e.g. in the scalp of a subject). The cosmetic methods also provide improved aesthetic results, particularly, more realistic and natural looking results, relative to the results obtained by traditional methods. The cosmetic methods are particularly suitable for hair transplantation in recipient areas of a subject experiencing baldness or lack of hair, optionally due to Androgenic alopecia, burn injuries, cancer chemotherapy, or other genetic or environmental factors or scarring.Type: GrantFiled: December 12, 2013Date of Patent: August 27, 2019Assignee: HAIR SCIENCE INSTITUTEInventor: Conradus Ghosal Gho
-
Patent number: 10335439Abstract: [Problem] To provide a method for producing human corneal epithelial sheet, wherein the human corneal epithelial-derived cells obtained by culturing human corneal epithelial cells are cultured on an amnion substrate. [Solution] A method for culturing human corneal epithelial cells using mesenchymal stem cells as the feeder cells; and a method for culturing human corneal epithelial cells using a medium containing a ROCK inhibitor, a phosphodiesterase inhibitor, a MAP kinase inhibitor and a TGF-? receptor inhibitor in various combinations.Type: GrantFiled: March 9, 2014Date of Patent: July 2, 2019Assignees: JCR Pharmaceuticals Co., Ltd., Kyoto Prefectural Public University CorporationInventors: Kiwamu Imagawa, Kenichi Maeda, Yuki Hosoda, Shuichi Yokoyama, Naoki Okumura, Noriko Koizumi, Shigeru Kinoshita
-
Patent number: 10330685Abstract: Provided herein is technology relating to treatment of sepsis and particularly, but not exclusively, to methods for predicting a response of a sepsis patient to treatment with L-carnitine.Type: GrantFiled: April 28, 2015Date of Patent: June 25, 2019Assignees: THE REGENTS OF THE UNIVERSITY OF MICHIGAN, UNIVERSITY OF MISSISSIPPI MEDICAL CENTERInventors: Kathleen Stringer, Alan E. Jones, Mike Puskarich
-
Patent number: 10322080Abstract: A method for reducing hyaluronidase activity and promoting hyaluronic acid production in skin comprising topically applying to skin in need thereof a composition comprising an effective amount of Centella asiatica stem cells to reduce hyaluronidase activity in skin, an effective amount of tetradecyl aminobutyroylvalylamino butyric urea trifluoroacetate to promote hyaluronic acid production in skin, and an effective amount of tripeptide-1 to promote hyaluronic acid production in skin.Type: GrantFiled: June 6, 2016Date of Patent: June 18, 2019Assignee: Mary Kay Inc.Inventors: Tiffany Florence, Michelle Hines, David Gan
-
Patent number: 10274479Abstract: The present invention provides a microfluidic device and its use for cell motility classification. The microfluidic device comprises a fluid inlet, a sample inlet and a channel connecting the fluid inlet and the sample inlet, wherein the channel comprises at least two sections of different sizes, and the channel allows fluid flow from the fluid inlet to the sample inlet.Type: GrantFiled: June 1, 2012Date of Patent: April 30, 2019Assignee: CapitalBio CorporationInventors: Tian Qiu, Rui Ma, Chao Han, Lan Xie, Jing Cheng
-
Patent number: 10272043Abstract: The present invention comprises methods and compositions for the reduction of oxalate in humans. For example, the invention provides methods and compositions for the delivery of one or more oxalate-reducing enzymes embedded in particle compositions. The compositions of the present invention are suitable in methods of treatment or prevention of oxalate-related conditions including, but not limited to, hyperoxaluria, absorptive hyperoxaluria, enteric hyperoxaluria, primary hyperoxaluria, idiopathic calcium oxalate kidney stone disease (urolithiasis), vulvodynia, oxalosis associated with end-stage renal disease, cardiac conductance disorders, inflammatory bowel disease, Crohn's disease, ulcerative colitis, and patients who have undergone gastrointestinal surgery and bariatric surgery (surgery for obesity), and/or who have undergone antibiotic treatment.Type: GrantFiled: October 27, 2014Date of Patent: April 30, 2019Assignee: OXTHERA INTELLECTUAL PROPERTY ABInventors: Qingshan Li, Harmeet Sidhu
-
Patent number: 10267769Abstract: A method for fixing a biological sample includes delivering energy through a biological sample that has been removed from a subject, while fixing the biological sample. A change in speed of the energy traveling through the biological sample is evaluated to monitor the progress of the fixation. A system for performing the method can include a transmitter that outputs the energy and a receiver configured to detect the transmitted energy. A computing device can evaluate the speed of the energy based on signals from the receiver.Type: GrantFiled: March 4, 2011Date of Patent: April 23, 2019Assignee: Ventana Medical Systems, Inc.Inventors: Michael Otter, David Chafin, Abbey Pierson, Jefferson Curtis Taft
-
Patent number: 10258673Abstract: The invention relates a pharmaceutical composition containing botulinum toxin and a mucopolysaccharide uses thereof with increased pharmacological activity and long lasting botulinum toxin effect.Type: GrantFiled: May 14, 2014Date of Patent: April 16, 2019Assignee: Bosti Trading Ltd.Inventors: Evgeny Pokushalov, Vladislav Fomenko, Nariman Salakhudinov
-
Patent number: 10241119Abstract: Methods for measuring and analyzing parathyroid hormone-related peptide (PTHrP) using LC-MS/MS, including applications of the methods thereof, are disclosed and discussed. Such methods can include, along with the use of an isotope-labeled internal standard, purifying PTHrP from a biological sample, proteolytically digesting the PTHrP, and measuring specific digestion products using the using LC-MS/MS.Type: GrantFiled: May 9, 2016Date of Patent: March 26, 2019Assignee: University of Utah Research FoundationInventors: Mark M. Kushnir, Alan L. Rockwood, A. Wayne Meikle
-
Patent number: 10212941Abstract: The present invention provides methods for development of a virulent bacteriophage-based treatment for the control of plant diseases caused by Xylella fastidiosa. The invention further provides methods of isolating and propagating bacteriophage virulent to X. fastidiosa in a Xanthomonas bacterial host and for treating or reducing symptoms of X. fastidiosa infection in a plant. The invention further provides methods of isolating and propagating bacteriophage virulent to Xanthomonas axonopodis pv. citri and for treating or reducing symptoms of Xanthomonas axonopodis pv. citri infection in a plant.Type: GrantFiled: June 6, 2016Date of Patent: February 26, 2019Assignee: The Texas A&M University SystemInventors: Carlos F. Gonzalez, Stephen J. Ahern, Mayukh Das, Ryland F. Young, III, Tushar Suvra Bhowmick